Researchers identify mechanism of rare blinding disorder
Published On Mon 29 Feb 2016 by Roddy Isles
Scientists have identified a key mechanism that damages the cornea in Meesmann epithelial corneal dystrophy, a rare blinding disorder which is passed from parents to their children.
Researchers at the Universities of Dundee and Ulster, working with colleagues in Denmark, have discovered that faults in a gene that is responsible for corneal cell structure and stability lead to protein misfolding and cell death.
Meesmann epithelial corneal dystrophy (MECD) is a rare inherited condition in which very small cysts (microcysts) form in the outer layer (epithelium) of the cornea. Symptoms include sensitivity to light (photophobia), blurred vision, foreign-body sensation and ruptured cysts. In its most severe form MECD leads to scarring and clouding of the central cornea and can result in blindness.
The same process examined by the researchers is also active in Alzheimer’s, cystic fibrosis and other eye disorders such as retinitis pigmentosa.
The research has been funded in the UK by Fight for Sight, Wellcome Trust and the Medical Research Council.
Previous research has identified 23 faults in the gene KRT12 and three in KRT3 that cause some degree of MECD. These genes encode keratins K12 and K3, respectively; cornea-specific proteins that bind together to form the internal scaffolding of cells in the cornea’s epithelial layer.
However, the means by which faulty K12 leads to microcysts forming and bursting was poorly understood.
In the current study, published in the journal Human Molecular Genetics, the researchers studied the structure of the cornea and the distribution of keratin in mice carrying the KT12 fault. The results were then compared to human tissue samples from the cornea.
Results showed that the corneal epithelium of the K12 mice was 50% thicker than in normal mice, with a disorganised cell structure and signs of cell fragility. There were also changes to the pattern of gene and protein activity in the cornea, with a set of keratin genes that were more or less active than normal and increased activity of a protein called CHOP, which is involved in cleaning up misfolded protein from cells.
A similar pattern of changes was seen in the human tissue samples from a patient with the same K12-Leu132Pro fault, compared to healthy human corneal tissue.
Professor Irwin McLean, Professor of Human Genetics in the College of Life Sciences at the University of Dundee, said, “We knew that protein misfolding was likely to play a role in Meesmann epithelial corneal dystrophy because of the critical location of the K12 fault but this is the first direct evidence of it.
“What we see is the protein signature of the unfolded protein response – a pathway that’s activated to clean up debris from misfolded protein. However prolonged activation of this pathway can trigger programmed cell death, and we think this is happening in both mouse and human cornea as the K12-Leu132Pro fault produces overwhelming keratin misfolding.”
Professor Tara Moore, group leader for vision science research in the School of Biomedical Science at Ulster University, said, “The apparent activation of the unfolded protein response in MECD adds to the evidence that the eye is highly susceptible to cellular stress, as we see in other disorders such as keratoconus, cataract and diabetic retinopathy. However we still need to establish the specific pathway involved. Our K12 model will prove useful both here and in future as a test bed for therapies that target corneal stress responses and other keratin disorders caused by similar genetic faults.”
Dr Dolores M Conroy, Director of Research at Fight for Sight, said, “The top priority for corneal research identified by the Sight Loss and Vision Priority Setting partnership was to answer the question of whether gene or stem cell therapies can be developed. Identifying the means by which a genetic fault causes harm is a vital step on that path.”
Notes to editors
Publication
Allen EHA, Courtney DG, Atkinson SD, Moore JE, Mairs L, Toftgaard Poulsen E, et al. Keratin 12 missense mutation induces the unfolded protein response and apoptosis in Meesmann epithelial corneal dystrophy. Hum Mol Genet. 2016.
Available from: https://hmg.oxfordjournals.org/content/early/2016/02/06/hmg.ddw001
Fight for Sight is the leading UK charity dedicated to funding pioneering research to prevent sight loss and treat eye disease. Fight for Sight is funding research at leading universities and hospitals throughout the UK.
Major achievements to date include: saving the sight of thousands of premature babies through understanding and controlling levels of oxygen delivery; restoring sight by establishing the UK Corneal Transplant Service enabling over 52,000 corneal transplants to take place; providing the funding for the research leading to the world’s first clinical trial for choroideremia; bringing hope to children with inherited eye disease by co-funding the team responsible for the world’s first gene therapy clinical trial; and identifying new genes responsible for glaucoma, retinitis pigmentosa, keratoconus and other corneal disorders, and Nance-Horan syndrome.
Fight for Sight’s current research programme is focusing on preventing and treating age-related macular degeneration, diabetic retinopathy, glaucoma, cataract and corneal disease. We are also funding research into the causes of childhood blindness and a large number of rare eye diseases.
http://www.fightforsight.org.uk/
The University of Dundee is the top ranked University in the UK for biological sciences, according to the 2014 Research Excellence Framework.
With high-quality teaching, world-leading research, and a £200 million investment in a compact, friendly campus with an unrivalled position in the heart of the city centre, the University of Dundee has been rated number one in Scotland for the past six years in the Times Higher Education Student Experience Survey. The University is the central hub for a multi-million pound biotechnology sector in the east of Scotland, which now accounts for 16% of the local economy. www.dundee.ac.uk
Ulster University is Northern Ireland’s largest university with over 25,000 students across four campuses. The University delivers career-focused education that is informed by its world-leading research across a wide range of sectorally significant areas including: computing and engineering, nursing, law, art and design, biomedical sciences and the creative industries. The 2014 Research Excellence Framework identified world-leading research across all subject areas, placing the institution in the top quarter of all UK universities. Biomedical sciences achieved a world leading rating of 100% for its research environment and Ulster University is now ranked as one of the top five UK universities for research power. Recognised as one of the world’s top 100 young universities, Ulster University is developing a new £250m campus in Belfast, which is due for completion in 2018. This major investment will provide a state-of-the-art teaching and learning facility, a research and innovation hub for the business sector, and a shared space for the local community.
For media enquiries contact:
Roddy Isles
Head of Corporate Communications
University of Dundee
Nethergate, Dundee, DD1 4HN
Tel: +44 (0)1382 384910
Mobile: 07800 581902
Email: r.isles@dundee.ac.uk